E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma

被引:8
作者
Chang-Lee, Shu Nu [1 ]
Hsu, Hsi-Hsien [2 ,3 ]
Shibu, Marthandam Asokan [4 ]
Ho, Tsung-Jung [5 ,6 ]
Tsai, Chih-Hao [4 ]
Chen, Ming-Cheng [7 ]
Tu, Chuan-Chou [8 ]
Viswanadha, Vijaya Padma [9 ]
Kuo, Wei-Wen [10 ]
Huang, Chih-Yang [4 ,5 ,11 ]
机构
[1] Asia Univ, Dept Healthcare Adm, Taichung 413, Taiwan
[2] Mackay Mem Hosp, Div Colorectal Surg, Taipei 104, Taiwan
[3] Mackay Med Nursing & Management Coll, Taipei 11260, Taiwan
[4] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan
[5] China Med Univ, Grad Inst Chinese Med, Taichung 404, Taiwan
[6] China Med Univ, Beigang Hosp, Chinese Med Dept, Yunlin 651, Taiwan
[7] Taichung Vet Gen Hosp, Div Colorectal Surg, Taichung 407, Taiwan
[8] Taichung Armed Force Gen Hosp, Div Chest Med, Dept Internal Med, Taichung 411, Taiwan
[9] Bharathiar Univ, Dept Biotechnol, Coimbatore 641046, Tamil Nadu, India
[10] China Med Univ, Dept Biol Sci & Technol, Taichung 402, Taiwan
[11] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 413, Taiwan
关键词
Estrogen; Estrogen receptor; peroxisome proliferator-activated receptor; Hepatocellular carcinoma; ESTROGEN-RECEPTOR-BETA; BREAST-CANCER CELLS; ACTIVATED-RECEPTOR; PEROXISOME PROLIFERATORS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; PROSTATE-CANCER; LIVER-CANCER; TUMOR; HEPATOCARCINOGENESIS;
D O I
10.1007/s12253-016-0136-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Peroxisome proliferator-activated receptor-alpha (PPAR alpha) is a member of the nuclear receptor superfamily involved in hepatocarcinogenesis in rodents. In previous studies on liver tumor tissues, PPAR alpha mRNA expression was found to be significantly higher and overexpression of ER alpha inhibited the PPAR alpha expression, cell-proliferation and also induced apoptosis in Hep3B cell. However, the role of ER beta is not known yet. Therefore, the aim of this study is to define the role of ER beta on PPAR alpha in Hep3B cells. The effect of PPAR alpha signaling cascade were monitored by inducing Hep3B cells by fenofibrate. Further the cells were transfected with pCMV-ER beta and the consequences of ER beta-overexpression on the PPAR alpha induced changes such as enhanced cell-proliferation and suppressed apoptosis were determined using western blot analysis and TUNEL assay. The EMSA was used to identify whether ER beta modulates PPAR alpha expression by binding to PPAR alpha promoter region to repress PPAR alpha promoter activity. In addition, the direct interaction between ER beta and PPAR alpha proteins was verified by co-immunoprecipitation assay. Our results show that the overexpressed ER beta not only attenuated the effects of fenofibrate to induce the levels of apoptosis protein such as Cyt.c, Caspase 9 and Caspase 3 but also inhibited the levels of survival protein such Bcl-xL, p-Bad, cyclin A and cyclin E. All these effects of E-2/ER beta resulted in the enhancement of mitochondria dependent apoptotic pathway and the attenuation of cell proliferation. Moreover, the overexpressed ER beta reduced the mRNA and protein levels of PPAR alpha and its downstream Acyl-CoA oxidase (ACO). EMSA results show that ER beta directly binds to PPRE and inhibit PPAR alpha gene expression and according to immunoprecipitation assay ER beta also binds strongly with PPAR alpha. The E-2/ER beta further inhibited the fenofibrate-induced nuclear translocation of PPAR alpha. Taken together, ER beta might directly downregulate PPAR alpha gene expression and inhibit the nuclear translocation to suppress the proliferation and induce the apoptosis of Hep3B cells.
引用
收藏
页码:477 / 485
页数:9
相关论文
共 36 条
  • [1] Akriviadis EA, 1998, BRIT J SURG, V85, P1319
  • [2] Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells
    Behrens, D.
    Gill, J. H.
    Fichtner, I.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2007, 274 (1-2) : 19 - 29
  • [3] The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations
    Bisteau, Xavier
    Caldez, Matias J.
    Kaldis, Philipp
    [J]. CANCERS, 2014, 6 (01) : 79 - 111
  • [4] Focus on hepatocellular carcinoma
    Bruix, J
    Boix, L
    Sala, M
    Llovet, JM
    [J]. CANCER CELL, 2004, 5 (03) : 215 - 219
  • [5] Estrogen and prostate cancer: An eclipsed truth in an androgen-dominated scenario
    Carruba, Giuseppe
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 102 (04) : 899 - 911
  • [6] Estrogen and Its Receptors in Cancer
    Chen, George G.
    Zeng, Qiang
    Tse, Gary M. K.
    [J]. MEDICINAL RESEARCH REVIEWS, 2008, 28 (06) : 954 - 974
  • [7] Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis
    Cheng, J
    Lee, EJ
    Madison, LD
    Lazennec, G
    [J]. FEBS LETTERS, 2004, 566 (1-3): : 169 - 172
  • [8] Human health risk assessment for peroxisome proliferators: More than 30 years of research
    Fidaleo, Marco
    [J]. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 2009, 61 (03) : 215 - 221
  • [9] Mechanism of action of the nongenotoxic peroxisome proliferators:: Role of che peroxisome proliferator-activated receptor α
    Gonzalez, FJ
    Peters, JM
    Cattley, RC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (22) : 1702 - 1709
  • [10] Suppression of mouse hepatocyte apoptosis by peroxisome proliferators:: role of PPARα and TNFα
    Hasmall, SC
    James, NH
    Macdonald, N
    Gonzalez, FJ
    Peters, JM
    Roberts, RA
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2000, 448 (02) : 193 - 200